WORK PLANS - Laserfiche WebLink

Home Browse Search

C ,� HSP-n /1� Infectious Disease Response and Preparedness Plan ""°'"""'"° July 25, 2022 This definition includes clear face coverings or cloth face coverings with a clear plastic panel that otherwise meet this definition and which may be used to facilitate communication with people who are deaf or hard-of-hearing or others who need to see a speaker's mouth or facial expressions to understand speech or sign language respectively. (9) "Infectious period" means the following time period, unless otherwise defined by CDPH regulation or order, in which case the CDPH definition shall apply: (A) For COVID-19 cases who develop COVID-19 symptoms, from two days before they first develop symptoms until all of the following are true: it has been 10 days since symptoms first appeared; 24 hours have passed with no fever, without the use of fever- reducing medications; and symptoms have improved. (B) For COVID-19 cases who never develop COVID-19 symptoms, from two days before until 10 days after the specimen for their first positive test for COVID-19 was collected. (10) "Respirator"means a respiratory protection device approved by the National Institute for Occupational Safety and Health(NIOSH)to protect the wearer from particulate matter, such as an N95 filtering facepiece respirator. (11)"Returned case"means a COVID-19 case who returned to work pursuant to subsection (c)(10) and did not develop any COVID-19 symptoms after returning. A person shall only be considered a returned case for 90 days after the initial onset of COVID-19 symptoms or, if the person never developed COVID-19 symptoms, for 90 days after the first positive test. If a period of other than 90 days is required by a CDPH regulation or order,that period shall apply. (12) "Worksite," for the limited purposes of sections 3205 through 3205.4 only, means the building, store, facility, agricultural field, or other location where a COVID-19 case was present during the infectious period.It does not apply to buildings,floors,or other locations of the employer that a COVID-19 case did not enter, locations where the worker worked by themselves without exposure to other employees, or to a worker's personal residence or alternative work location chosen by the worker when working remotely. Note: The term worksite is used for the purpose of notice requirements in subsections (c)(3)(B)3. and 4. only. (c) Written COVID-19 Prevention Program. Employers shall establish, implement, and maintain an effective,written COVID-19 Prevention Program,which may be integrated into the employer's Injury and Illness Prevention Program required by section 3203, or be maintained in a separate document. The written elements of a COVID-19 Prevention Program shall include: (1) System for communicating. The employer shall do all of the following in a form readily understandable by employees: (A) Ask employees to report to the employer, without fear of reprisal, COVID-19 symptoms,possible close contacts, and possible COVID-19 hazards at the workplace. (B) Describe how employees with medical or other conditions that put them at increased risk of severe COVID-19 illness can request accommodations. (C) Provide information about access to COVID-19 testing as described in subsection (c)(5)(I) when testing is required under this section, section 3205.1, or section 3205.2.